[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BRPI0817199A2 - IDENTIFICATIONB AND INSULATION OF FETAL CELLS AND NUCLEIC ACID - Google Patents

IDENTIFICATIONB AND INSULATION OF FETAL CELLS AND NUCLEIC ACID

Info

Publication number
BRPI0817199A2
BRPI0817199A2 BRPI0817199-8A2A BRPI0817199A BRPI0817199A2 BR PI0817199 A2 BRPI0817199 A2 BR PI0817199A2 BR PI0817199 A BRPI0817199 A BR PI0817199A BR PI0817199 A2 BRPI0817199 A2 BR PI0817199A2
Authority
BR
Brazil
Prior art keywords
identificationb
insulation
nucleic acid
fetal cells
fetal
Prior art date
Application number
BRPI0817199-8A2A
Other languages
Portuguese (pt)
Inventor
Farideh Bischoff
Original Assignee
Biocept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocept Inc filed Critical Biocept Inc
Publication of BRPI0817199A2 publication Critical patent/BRPI0817199A2/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BRPI0817199-8A2A 2007-09-21 2008-09-22 IDENTIFICATIONB AND INSULATION OF FETAL CELLS AND NUCLEIC ACID BRPI0817199A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97439207P 2007-09-21 2007-09-21
PCT/US2008/077251 WO2009039507A2 (en) 2007-09-21 2008-09-22 Identification and isolation of fetal cells and nucleic acid

Publications (1)

Publication Number Publication Date
BRPI0817199A2 true BRPI0817199A2 (en) 2014-10-14

Family

ID=40468814

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817199-8A2A BRPI0817199A2 (en) 2007-09-21 2008-09-22 IDENTIFICATIONB AND INSULATION OF FETAL CELLS AND NUCLEIC ACID

Country Status (12)

Country Link
EP (1) EP2207879A4 (en)
JP (1) JP2010539906A (en)
KR (1) KR20100061539A (en)
CN (1) CN101883851A (en)
AU (1) AU2008302040A1 (en)
BR (1) BRPI0817199A2 (en)
CA (1) CA2699958A1 (en)
IL (1) IL204585A0 (en)
MX (1) MX2010003116A (en)
NZ (1) NZ584165A (en)
WO (1) WO2009039507A2 (en)
ZA (1) ZA201001912B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476013B2 (en) * 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
JP5923035B2 (en) 2009-03-24 2016-05-24 バイオセプト インコーポレイティッド Devices and methods for cell capture and analysis
US20120100538A1 (en) 2009-03-24 2012-04-26 Biocept, Inc. Devices and methods of cell capture and analysis
EP3088532B1 (en) 2009-12-22 2019-10-30 Sequenom, Inc. Processes and kits for identifying aneuploidy
EP4155401A1 (en) 2012-03-02 2023-03-29 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
EP4008270A1 (en) 2012-06-22 2022-06-08 Preprogen LLC Method for obtaining fetal cells and fetal cellular components
US20140093873A1 (en) 2012-07-13 2014-04-03 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
EP3597774A1 (en) 2013-03-13 2020-01-22 Sequenom, Inc. Primers for dna methylation analysis
EP3736344A1 (en) 2014-03-13 2020-11-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
WO2018181274A1 (en) * 2017-03-27 2018-10-04 積水メディカル株式会社 Method for concentrating and collecting target nucleic acid using antibody

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09510875A (en) * 1994-03-29 1997-11-04 ジェンザイム・コーポレイション Culture and isolation of fetal cells from maternal peripheral blood
EP1483415A4 (en) * 2002-02-20 2006-02-01 Univ Virginia A non-invasive diagnostic test utilizing histone modification markers
GB0211904D0 (en) * 2002-05-23 2002-07-03 Medical Res Council Nuclear transfer
US20050181429A1 (en) * 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20040197832A1 (en) * 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
WO2007121276A2 (en) 2006-04-12 2007-10-25 Biocept, Inc. Enrichment of circulating fetal dna

Also Published As

Publication number Publication date
IL204585A0 (en) 2010-11-30
WO2009039507A2 (en) 2009-03-26
ZA201001912B (en) 2011-05-25
KR20100061539A (en) 2010-06-07
AU2008302040A1 (en) 2009-03-26
JP2010539906A (en) 2010-12-24
NZ584165A (en) 2012-09-28
CN101883851A (en) 2010-11-10
CA2699958A1 (en) 2009-03-26
EP2207879A2 (en) 2010-07-21
EP2207879A4 (en) 2011-01-26
WO2009039507A3 (en) 2009-06-18
MX2010003116A (en) 2010-08-03

Similar Documents

Publication Publication Date Title
BRPI0817199A2 (en) IDENTIFICATIONB AND INSULATION OF FETAL CELLS AND NUCLEIC ACID
DK2574677T3 (en) Methods of cell culture
DK3495498T3 (en) GENE EXPRESSION ANALYSIS IN SINGLE CELLS
DK2129797T3 (en) nucleic acid detection
GB0701253D0 (en) Nucleic acid amplification and testing
BRPI0908128A2 (en) Method for Isolation of Cell Free Apoptotic or Fetal Nucleic Acids
HK1171083A1 (en) Nucleic acid analysis
IL214034A0 (en) Single -cell nucleic acid analysis
DK2626438T3 (en) PRESERVATION OF Fetal NUCLEIC ACIDS IN MATERNAL PLASMA
EP2476053A4 (en) Analysis of cell networks
BRPI1010035A2 (en) Fucosylation-deficient cells
BR112012014158A2 (en) "electrochemical cell"
DK1984502T3 (en) nucleic acid
GB0814570D0 (en) Isolation of nucleic acid
BRPI0820738A2 (en) Gender-specific separation of sperm and embryo cells
EP2132334A4 (en) Methods and compositions related to nucleic acid detection
BRPI0907886A2 (en) Lithium cell
HK1142928A1 (en) Nucleic acid amplification in the presence of modified randomers
FI20085039A0 (en) Nucleic acid probes and broad spectrum primers
BRPI0813388A2 (en) METHODS AND COMPOSITIONS FOR NUCLEIC ACID AMPLIFICATION
EP2118297A4 (en) Generation of nucleic acid molecules
GB0807321D0 (en) Analysis of nucleic acids
BRPI1010684A2 (en) method to determine the cardioregenerative potential of mammalian cells
DK2511369T3 (en) Protease-stable cell wall lysing enzymes
EP2300488A4 (en) Cell lysis reagent for isolation of rna

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]